Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the russian diabetes registry

Data on the national level and worldwide show a higher rate of mortality in patients with diabetes mellitus (DM) due to COVID-19, which determines the high relevance of risk factor analysis for outcomes in DM patients to substantiate the strategy for this category of patients. To assess the effect o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Problemy endokrinologii 2020-08, Vol.66 (1), p.35-46
Hauptverfasser:	Shestakova, Marina V, Vikulova, Olga K, Isakov, Mikhail А, Dedov, Ivan I
Format:	Artikel
Sprache:	eng ; rus
Schlagworte:	Aged Aged, 80 and over Angiotensin Receptor Antagonists - therapeutic use Angiotensin-Converting Enzyme Inhibitors - adverse effects Angiotensin-Converting Enzyme Inhibitors - therapeutic use Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use COVID-19 - complications COVID-19 - drug therapy COVID-19 - mortality COVID-19 - virology Diabetes Complications - drug therapy Diabetes Complications - mortality Diabetes Complications - virology Diabetes Mellitus - drug therapy Diabetes Mellitus - mortality Diabetes Mellitus - virology Diuretics - adverse effects Diuretics - therapeutic use Female Humans Hypertension - complications Hypertension - drug therapy Hypertension - mortality Hypertension - virology Insulin - metabolism Male Metformin - adverse effects Metformin - therapeutic use Russia - epidemiology SARS-CoV-2 - pathogenicity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!